ID

15669

Descripción

Pilot Trial of EGF Ointment for the Patients With EGFR-i Related Skin Side Effects; ODM derived from: https://clinicaltrials.gov/show/NCT02284139

Link

https://clinicaltrials.gov/show/NCT02284139

Palabras clave

Versiones (1)
  1. 7/6/16 7/6/16 -
Subido en

7 de junio de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Non-small Cell Lung Cancer NCT02284139

Inglés

Eligibility Non-small Cell Lung Cancer NCT02284139

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. age: older than 20
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
2. eastern cooperative oncology group (ecog) performance status 0 -2
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
3. histologically confirmed lung cancer, pancreatic cancer, or colon cancer
Descripción

Malignant neoplasm of lung | Pancreatic carcinoma | Malignant tumor of colon

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0242379
UMLS CUI [2]
C0235974
UMLS CUI [3]
C0007102
4. patients take egfr inhibitor following the reason
Descripción

Epidermal growth factor receptor inhibitor

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1443775
egfr mutation (+) nsclc - adenocarcinoma for 1st line treatment
Descripción

EGFR gene mutation Non-Small Cell Lung Carcinoma | Adenocarcinoma First line treatment

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3266992
UMLS CUI [1,2]
C0007131
UMLS CUI [2,1]
C0001418
UMLS CUI [2,2]
C1708063
nsclc - for ≥ 2nd line treatment
Descripción

Non-Small Cell Lung Carcinoma | Second line treatment

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0007131
UMLS CUI [2]
C1710038
pancreatic cancer - adenocarcinoma for 1st line treatment with gemcitabine
Descripción

Pancreatic carcinoma | Adenocarcinoma First line treatment gemcitabine

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0235974
UMLS CUI [2,1]
C0001418
UMLS CUI [2,2]
C1708063
UMLS CUI [2,3]
C0045093
colon cancer - adenocarcinoma 1st line treatment with irinotecan (folfiri)
Descripción

Malignant tumor of colon | Adenocarcinoma First line treatment irinotecan Folinic Acid-Fluorouracil-Irinotecan Regimen

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0007102
UMLS CUI [2,1]
C0001418
UMLS CUI [2,2]
C1708063
UMLS CUI [2,3]
C0123931
UMLS CUI [2,4]
C1880658
5. patients who have egfr inhibitor related skin side effects (erse) gr≥2 (ncictc v4.0)
Descripción

Skin side effects Due to Epidermal growth factor receptor inhibitor

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1123023
UMLS CUI [1,2]
C0879626
UMLS CUI [1,3]
C0678226
UMLS CUI [1,4]
C1443775
6. a patient with the willingness to comply with the study protocol during the study period and capable of complying with it
Descripción

Compliance behavior Study Protocol

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C2348563
7. a patient who signed the informed consent prior to the participation of the study and who understands that he/she has a right to withdrawal from participation in the study at any time without any disadvantages
Descripción

Informed consent | Study Subject Participation Status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2]
C2348568
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. a patient with previous active or passive immunotherapy
Descripción

Prior Immunotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1514461
2. a pregnant or lactating patient
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
3. a patient of childbearing potential without being tested for pregnancy at baseline for positive. (a postmenopausal woman with the amenorrhea period of at least 12 months or longer is considered to have non-childbearing potential.)
Descripción

Childbearing Potential | Pregnancy test positive Absent | Postmenopausal state | Amenorrhea Period

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3831118
UMLS CUI [2,1]
C0240802
UMLS CUI [2,2]
C0332197
UMLS CUI [3]
C0232970
UMLS CUI [4,1]
C0002453
UMLS CUI [4,2]
C1948053
4. a patient with history of uncontrolled seizures, central nervous system disorder or psychiatric disorders that are considered clinically significant by the investigator that would prohibit the understanding of informed consent or that may be considered to interfere with the compliance of the administration of the study medications
Descripción

Seizures Uncontrolled | CNS disorder | Mental disorders | Informed Consent Unable | Compliance behavior Limited

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0036572
UMLS CUI [1,2]
C0205318
UMLS CUI [2]
C0007682
UMLS CUI [3]
C0004936
UMLS CUI [4,1]
C0021430
UMLS CUI [4,2]
C1299582
UMLS CUI [5,1]
C1321605
UMLS CUI [5,2]
C0439801
5. a patient with history of dermatologic care (except transient urticaria) within 4 weeks
Descripción

Care Dermatologic | Urticaria Transient

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1947933
UMLS CUI [1,2]
C0205489
UMLS CUI [2,1]
C0042109
UMLS CUI [2,2]
C0205374
6. a patient with clinically significant (i.e. active) heart disease (e.g. congestive heart failure, symptomatic coronary artery diseases, cardiac arrhythmias, etc) or myocardial infarction within past 12 months
Descripción

Heart Diseases | Congestive heart failure | Coronary Artery Disease Symptomatic | Cardiac Arrhythmia | Myocardial Infarction

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0018799
UMLS CUI [2]
C0018802
UMLS CUI [3,1]
C1956346
UMLS CUI [3,2]
C0231220
UMLS CUI [4]
C0003811
UMLS CUI [5]
C0027051
7. a patient with interstitial pneumonia or diffused symptomatic fibrosis of the lungs.
Descripción

Pneumonia, Interstitial | Pulmonary Fibrosis Diffused Symptomatic

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0206061
UMLS CUI [2,1]
C0034069
UMLS CUI [2,2]
C0012222
UMLS CUI [2,3]
C0231220
8. organ allogenic transplantation requiring immunosuppressive therapy. any waiver of these inclusion and exclusion criteria must be approved by the investigator and the sponsor on a case-by case basis prior to enrolling the subject
Descripción

Transplantation, Homologous | Therapeutic immunosuppression

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0040739
UMLS CUI [2]
C0021079
9. known allergies, hypersensitivity, or intolerance to study drugs, chemotherapy drugs using this clinical trial
Descripción

Hypersensitivity Investigational New Drugs | intolerance to Investigational New Drugs | Hypersensitivity Chemotherapy Pharmaceutical Preparations | intolerance to Chemotherapy Pharmaceutical Preparations

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C1744706
UMLS CUI [2,2]
C0013230
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0392920
UMLS CUI [3,3]
C0013227
UMLS CUI [4,1]
C1744706
UMLS CUI [4,2]
C0392920
UMLS CUI [4,3]
C0013227
Volver a la parte superior de la página

Similar models

Eligibility Non-small Cell Lung Cancer NCT02284139

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
1. age: older than 20
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
2. eastern cooperative oncology group (ecog) performance status 0 -2
boolean
C1520224 (UMLS CUI [1])
Malignant neoplasm of lung | Pancreatic carcinoma | Malignant tumor of colon
Item
3. histologically confirmed lung cancer, pancreatic cancer, or colon cancer
boolean
C0242379 (UMLS CUI [1])
C0235974 (UMLS CUI [2])
C0007102 (UMLS CUI [3])
Epidermal growth factor receptor inhibitor
Item
4. patients take egfr inhibitor following the reason
boolean
C1443775 (UMLS CUI [1])
EGFR gene mutation Non-Small Cell Lung Carcinoma | Adenocarcinoma First line treatment
Item
egfr mutation (+) nsclc - adenocarcinoma for 1st line treatment
boolean
C3266992 (UMLS CUI [1,1])
C0007131 (UMLS CUI [1,2])
C0001418 (UMLS CUI [2,1])
C1708063 (UMLS CUI [2,2])
Non-Small Cell Lung Carcinoma | Second line treatment
Item
nsclc - for ≥ 2nd line treatment
boolean
C0007131 (UMLS CUI [1])
C1710038 (UMLS CUI [2])
Pancreatic carcinoma | Adenocarcinoma First line treatment gemcitabine
Item
pancreatic cancer - adenocarcinoma for 1st line treatment with gemcitabine
boolean
C0235974 (UMLS CUI [1])
C0001418 (UMLS CUI [2,1])
C1708063 (UMLS CUI [2,2])
C0045093 (UMLS CUI [2,3])
Malignant tumor of colon | Adenocarcinoma First line treatment irinotecan Folinic Acid-Fluorouracil-Irinotecan Regimen
Item
colon cancer - adenocarcinoma 1st line treatment with irinotecan (folfiri)
boolean
C0007102 (UMLS CUI [1])
C0001418 (UMLS CUI [2,1])
C1708063 (UMLS CUI [2,2])
C0123931 (UMLS CUI [2,3])
C1880658 (UMLS CUI [2,4])
Skin side effects Due to Epidermal growth factor receptor inhibitor
Item
5. patients who have egfr inhibitor related skin side effects (erse) gr≥2 (ncictc v4.0)
boolean
C1123023 (UMLS CUI [1,1])
C0879626 (UMLS CUI [1,2])
C0678226 (UMLS CUI [1,3])
C1443775 (UMLS CUI [1,4])
Compliance behavior Study Protocol
Item
6. a patient with the willingness to comply with the study protocol during the study period and capable of complying with it
boolean
C1321605 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Informed consent | Study Subject Participation Status
Item
7. a patient who signed the informed consent prior to the participation of the study and who understands that he/she has a right to withdrawal from participation in the study at any time without any disadvantages
boolean
C0021430 (UMLS CUI [1])
C2348568 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Prior Immunotherapy
Item
1. a patient with previous active or passive immunotherapy
boolean
C1514461 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
2. a pregnant or lactating patient
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Childbearing Potential | Pregnancy test positive Absent | Postmenopausal state | Amenorrhea Period
Item
3. a patient of childbearing potential without being tested for pregnancy at baseline for positive. (a postmenopausal woman with the amenorrhea period of at least 12 months or longer is considered to have non-childbearing potential.)
boolean
C3831118 (UMLS CUI [1])
C0240802 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0232970 (UMLS CUI [3])
C0002453 (UMLS CUI [4,1])
C1948053 (UMLS CUI [4,2])
Seizures Uncontrolled | CNS disorder | Mental disorders | Informed Consent Unable | Compliance behavior Limited
Item
4. a patient with history of uncontrolled seizures, central nervous system disorder or psychiatric disorders that are considered clinically significant by the investigator that would prohibit the understanding of informed consent or that may be considered to interfere with the compliance of the administration of the study medications
boolean
C0036572 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0007682 (UMLS CUI [2])
C0004936 (UMLS CUI [3])
C0021430 (UMLS CUI [4,1])
C1299582 (UMLS CUI [4,2])
C1321605 (UMLS CUI [5,1])
C0439801 (UMLS CUI [5,2])
Care Dermatologic | Urticaria Transient
Item
5. a patient with history of dermatologic care (except transient urticaria) within 4 weeks
boolean
C1947933 (UMLS CUI [1,1])
C0205489 (UMLS CUI [1,2])
C0042109 (UMLS CUI [2,1])
C0205374 (UMLS CUI [2,2])
Heart Diseases | Congestive heart failure | Coronary Artery Disease Symptomatic | Cardiac Arrhythmia | Myocardial Infarction
Item
6. a patient with clinically significant (i.e. active) heart disease (e.g. congestive heart failure, symptomatic coronary artery diseases, cardiac arrhythmias, etc) or myocardial infarction within past 12 months
boolean
C0018799 (UMLS CUI [1])
C0018802 (UMLS CUI [2])
C1956346 (UMLS CUI [3,1])
C0231220 (UMLS CUI [3,2])
C0003811 (UMLS CUI [4])
C0027051 (UMLS CUI [5])
Pneumonia, Interstitial | Pulmonary Fibrosis Diffused Symptomatic
Item
7. a patient with interstitial pneumonia or diffused symptomatic fibrosis of the lungs.
boolean
C0206061 (UMLS CUI [1])
C0034069 (UMLS CUI [2,1])
C0012222 (UMLS CUI [2,2])
C0231220 (UMLS CUI [2,3])
Transplantation, Homologous | Therapeutic immunosuppression
Item
8. organ allogenic transplantation requiring immunosuppressive therapy. any waiver of these inclusion and exclusion criteria must be approved by the investigator and the sponsor on a case-by case basis prior to enrolling the subject
boolean
C0040739 (UMLS CUI [1])
C0021079 (UMLS CUI [2])
Hypersensitivity Investigational New Drugs | intolerance to Investigational New Drugs | Hypersensitivity Chemotherapy Pharmaceutical Preparations | intolerance to Chemotherapy Pharmaceutical Preparations
Item
9. known allergies, hypersensitivity, or intolerance to study drugs, chemotherapy drugs using this clinical trial
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C1744706 (UMLS CUI [2,1])
C0013230 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0392920 (UMLS CUI [3,2])
C0013227 (UMLS CUI [3,3])
C1744706 (UMLS CUI [4,1])
C0392920 (UMLS CUI [4,2])
C0013227 (UMLS CUI [4,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial